Skip to content

Chapter 313: Mechanical Ventilatory Support

Part 8: Critical Care Medicine

KEY CLINICAL POINTS

  • Mechanical ventilation is critical for patients with hypoxemic or hypercapnic respiratory failure, ARDS, and airway obstruction.
  • Optimal ventilation requires balancing tidal volume (6-8 mL/kg IBW), PEEP, and respiratory rate to prevent barotrauma and volume trauma.
  • Noninvasive ventilation (NIV) is beneficial for acute respiratory failure with reversible causes, reducing ICU admission and intubation.
  • Ventilator-associated pneumonia (VAP) is a major complication, with prevention strategies including head-of-bed elevation and daily sedation interruption.
  • Successful weaning from mechanical ventilation depends on resolving the underlying disease, adequate respiratory drive, and minimal secretions.

1. DEFINITION & OVERVIEW

Mechanical ventilation delivers positive pressure gas to patients with acute/chronic respiratory failure. Hypoxemic failure is due to ventilation-perfusion mismatch (e.g., ARDS, pneumonia), while hypercapnic failure is caused by obstructive lung disease (COPD, asthma) or neuromuscular disorders. Noninvasive ventilation (NIV) is used for patients with intact airway protection.

Table 313-1: Key Features of Commonly Used Mechanical Ventilation Modes

MODE VARIABLES SET BY CLINICIAN (INDEPENDENT) MONITORED VARIABLES (DEPENDENT) ADVANTAGES DISADVANTAGES
Assist control–volume control VT, Respiratory rate, PEEP, FIO2, Inspiratory flow rate Peak inspiratory pressure, End-inhalation pressure, VE Guarantees minimum VT and VE Barotrauma from high plateau pressure, Patient-ventilator dyssynchrony
Assist control–pressure control Inspiratory driving pressure, Respiratory rate, PEEP, FIO2 VT, VE Limits barotrauma if patient effort minimal Variable VT due to changing compliance
Pressure-regulated volume control VT, Respiratory rate, PEEP, FIO2 Peak inspiratory pressure, End-inhal, VE Patient effort varies inspiratory flow VT may exceed set values
Pressure support FIO2, PEEP, Maximum inspiratory pressure VT, VE, Respiratory rate Preserves patient effort Apnea/hypoventilatio n possible

Table 313-2: Common Contraindications to Noninvasive Ventilation

CONTRAINDICATION
Inability to protect the airway (e.g., severe encephalopathy)
High risk for aspiration (e.g., vomiting, upper GI bleeding)
Difficulty clearing respiratory secretions
Facial trauma/surgery, upper airway obstruction
Significant hemodynamic instability

1.1 ARDS and Lung Recovery

ARDS survivors often regain near-normal lung function within 6 months, but long-term sequelae include exercise limitation and reduced quality of life. Recovery correlates with initial lung injury severity (e.g., static compliance, PEEP requirements). Psychological comorbidities (depression, PTSD) are common in survivors.

1.2 Ventilator Mechanics

Positive pressure ventilation inflates lungs via transpulmonary pressure. In ARDS, stiff lungs require higher pressures for tidal volumes, risking respiratory muscle fatigue. Ventilator settings must balance oxygenation, CO2 removal, and lung protection.

2. PRINCIPLES OF MECHANICAL VENTILATION

Optimal ventilation requires balancing tidal volume (6-8 mL/kg IBW), PEEP, and respiratory rate to prevent barotrauma and volume trauma. Pressure-regulated volume control (PRVC) adapts to patient effort while maintaining target VT. PEEP should be set at the lower inflection point of the pressure-volume curve to prevent alveolar collapse.

Table 313-3: Adverse Effects of Hypercapnia

ADVERSE EFFECT
Pulmonary arterial vasoconstriction (right heart failure)
Rightward shift of oxyhemoglobin curve
Cerebral vasodilation and increased ICP
Sympathetic-adrenal stimulation
Reduced cardiac contractility (especially with b-blockers)

2.1 Tidal Volume and PEEP Optimization

Low tidal volume (6 mL/kg IBW) and moderate PEEP (5-10 cmH2O) reduce lung injury. Higher PEEP (10-20 cmH2O) may be needed for ARDS to prevent atelectasis. End-inspiratory pressure should remain <30 cmH2O to avoid overdistension.

2.2 Ventilation Modes

Volume control (AC) guarantees VT but risks barotrauma. Pressure control (PCV) limits peak pressure but allows variable VT. Pressure support (PSV) preserves patient effort but may lead to hypoventilation.

3. MECHANICAL VENTILATION MODES

Assist control (AC), pressure control (PCV), pressure support (PSV), and volume support modes are used based on patient needs. NIV (CPAP/BiPAP) is preferred for reversible respiratory failure. PRVC adapts to patient effort while maintaining target VT.

3.1 Assist Control (AC)

Clinician controls VT, respiratory rate, PEEP, and FIO2. Patients can trigger additional breaths. Risks include barotrauma and dyssynchrony.

3.2 Pressure Control (PCV)

Inspiratory pressure is set, with VT dependent on lung compliance. Limits peak pressure but may result in variable VT. Used in ARDS to prevent overdistension.

3.3 Pressure Support (PSV)

Patient-initiated breaths are supported by preset pressure. Preserves spontaneous breathing but may lead to hypoventilation if patient effort is inadequate.

4. NONINVASIVE POSITIVE PRESSURE VENTILATION

NIV (CPAP/BiPAP) is used for acute respiratory failure with reversible causes (e.g., COPD exacerbations). It improves gas exchange and reduces ICU admission. Contraindications include inability to protect the airway or hemodynamic instability.

4.1 Indications and Outcomes

NIV reduces intubation rates in COPD exacerbations and acute cardiogenic pulmonary edema. Nocturnal NIV improves outcomes in hypercapnic patients with chronic respiratory failure.

4.2 Risks and Monitoring

PES (post-extubation stridor) risk factors include prolonged intubation, trauma, or previous PES. Cuff leak tests help identify PES risk. Monitor for hypercapnia and ventilatory effort.

5. COMPLICATIONS OF MECHANICAL VENTILATION

Common complications include ventilator-associated pneumonia (VAP), barotrauma (pneumothorax, pneumomediastinum), and hypercapnia. Prolonged ventilation increases risk of ICU-acquired weakness and delirium.

5.1 Airway Complications

Endotracheal tube placement can cause vocal cord injury, tracheal stenosis, or stricture. PES risk factors include prolonged intubation, trauma, or previous PES.

5.2 Hypercapnia and Acidosis

Hypercapnia causes pulmonary vasoconstriction, increased ICP, and reduced cardiac contractility. Permissive hypercapnia may be tolerated down to pH 7.2 but requires monitoring.

5.3 Ventilator-Associated Pneumonia

VAP occurs in 15% of ventilated patients, with mortality ~50%. Prevention includes head-of-bed elevation, daily sedation interruption, and strict hand hygiene.

6. LIBERATION FROM MECHANICAL VENTILATION

Weaning involves assessing readiness for spontaneous breathing, often via spontaneous breathing trial (SBT). Criteria include FIO2 <0.5, PEEP <8 cmH2O, SaO2 >90%, and stable hemodynamics.

Table 313-4: Algorithm for Discontinuing Mechanical Ventilation

STEP CRITERIA
1 Underlying process improved, patient awake, minimal sedation
2 FIO2 £0.5, PEEP <8 cmH2O, SaO2 >88%
3 Stable hemodynamics, minimal secretions, adequate cough
4 Spontaneous breathing trial (SBT) with pressure support 5-7 cmH2O
5 SBT success: RR <35, SaO2 >90%, no anxiety/diaphoresis
6 Extubation with NIV or high-flow O2 for high-risk patients

6.1 Spontaneous Breathing Trial (SBT)

SBT uses minimal pressure support (5-7 cmH2O) to assess respiratory effort. Success criteria: comfortable breathing, RR <35, SaO2 >90%, and minimal secretions.

6.2 Weaning Algorithms

Algorithm includes daily readiness assessment, SBT, and transition to NIV or high-flow oxygen. High-risk patients (age >65, COPD, APACHE-II >12) require closer monitoring.

7. KEY POINTS & CLINICAL PEARLS

  1. Use low tidal volumes (6 mL/kg IBW) and moderate PEEP to prevent lung injury.
  2. Monitor for hypercapnia and adjust ventilator settings to avoid barotrauma.
  3. NIV is effective for acute respiratory failure with reversible causes but has contraindications.
  4. Weaning success depends on resolving the underlying disease and adequate respiratory drive.
  5. Early mobilization and daily sedation interruption reduce ICU-acquired weakness.